期刊文献+
共找到760篇文章
< 1 2 38 >
每页显示 20 50 100
Effect of Xiaoyu Zhixue Tablet (消瘀止血片) on Expression ofPlatelet Membrane Glycoproteins in Patients withHemorrhagic Thrombopathy 被引量:5
1
作者 沈霖 沈迪 +4 位作者 高兰 刘仲萍 杨艳萍 谢晶 周丕琪 《Chinese Journal of Integrated Traditional and Western Medicine》 2004年第3期170-174,共5页
Objective: To observe the effect of Xiaoyu Zhixue tablet (消瘀止血片,XYZXT) on the expression of platelet membrane glycoproteins in patients with hemorrhagic thrombopathy, and to explore its possible mechanism. Method... Objective: To observe the effect of Xiaoyu Zhixue tablet (消瘀止血片,XYZXT) on the expression of platelet membrane glycoproteins in patients with hemorrhagic thrombopathy, and to explore its possible mechanism. Methods: The total of 148 patients with hemorrhagic thrombopathy were randomly divided into two groups, the traditional Chinese medicicne (TCM) group (n=98) treated with XYZXT and the Western medicine (WM) group (n=50) treated with adrenosin, vitamins C, K and P, both for 6 months. The therapeutic effect and the recovery rate of platelet aggregation in the two groups were observed. And platelet membrane glycoprotein (GP) Ⅰb/Ⅸ, GPⅡb/Ⅲa complexes, GPⅠb, GPⅡb, GP Ⅲa and P-selectin were analyzed by flow cytometry in both groups before and after treatment and also in 34 normal healthy subjects. Results: The total effective rate of hemostasis was 89. 8% in TCM group and 54. 0% in the WM group (x2=45.83, P<0.01), and the recovery rate of platelet aggregation was 72.4% and 4.0% respectively (x2=62.06, P<0.01). The fluorescence intensity of GP Ⅰ b/Ⅸ, GPⅡb/Ⅲa complexes, GPⅠb, GPⅢa and P-selectin were lower in both groups before treatment than those in the healthy subjects. Expression of above-mentioned marks was elevated in TCM group after 6 months' therapy, which was insignificantly different as compared with the healthy subjects (P>0.05) and higher than those in the WM group (P<0.05). Conclusion: One of the mechanisms in treating hemorrhagic thrombopathy with XYZXT is that it could regulate the expression of GP Ⅰb/Ⅸ, GPⅡ b/Ⅲa complexes, GPⅠb, GPⅢa and P-selectin at the level of receptor protein. 展开更多
关键词 hemorrhagic thrombopathy Xiaoyu Zhixue tablet platelet membrane glycoproteins
下载PDF
Expression of Platelet Membrane Glycoprotein Ib/Ⅸ/Ⅴ Complex,a Receptor of Thrombin,in Patients with Hemorrhagic Thrombopathy 被引量:3
2
作者 沈霖 沈迪 +4 位作者 朱锐 朱闽 卢芙蓉 秦铀 范恒 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2008年第6期657-659,共3页
To investigate the role of platelet membrane glycoprotein (GP) Ib/Ⅸ/Ⅴ complex and its subunit GP Ibα in patients with hemorrhagic thrombopathy (HT), the expressions of GP Ib/Ⅸ/Ⅴ complex and GP Ibα,defined as... To investigate the role of platelet membrane glycoprotein (GP) Ib/Ⅸ/Ⅴ complex and its subunit GP Ibα in patients with hemorrhagic thrombopathy (HT), the expressions of GP Ib/Ⅸ/Ⅴ complex and GP Ibα,defined as mean fluorescence intensity (MFI), were assessed by flow cytometry. The maximum aggregation of platelet was determined by turbidity method. These indicators were compared among 68 HT patients with the presenting complaint of hemorrhage, 33 well-controlled HT patients and 32 normal healthy subjects. The results showed that the MFI of GP Ib/Ⅸ /Ⅴ complex and GP Ibα was markedly lower in HT patients with current hemorrhage than that in the healthy subjects, with difference being statistically significant (P〈0.05). There was no significant difference in the expressions of GP Ib/ Ⅸ/ Ⅴ complex and GP Ibα between well-controlled HT patients and normal healthy subjects (P〉0.05). It was concluded that the expression of GP Ib/Ⅸ /Ⅴ complex, the receptor of thrombin and von Willebrand factor, was down-regulated in HT patients with current hemorrhage, which might result in the dysfunction of platelet aggregation and recurrence of HT. 展开更多
关键词 platelet membrane glycoproteins hemorrhagic thrombopathy thrombin receptor PLATELETAGGREGATION
下载PDF
Association of the Platelet Membrane Glycoprotein Ⅰa C807T Gene Polymorphism with Aspirin Resistance 被引量:1
3
作者 苏冠华 王朝晖 +2 位作者 丁艳萍 刘晓倩 王珏 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2007年第6期664-667,共4页
To explore the correlation between the C807T polymorphism of platelet membrane glycoprotein Ⅰa (GP Ⅰa) gene and aspirin resistance in Chinese people, 200 patients with high-risk of atherosclerosis took aspirin (1... To explore the correlation between the C807T polymorphism of platelet membrane glycoprotein Ⅰa (GP Ⅰa) gene and aspirin resistance in Chinese people, 200 patients with high-risk of atherosclerosis took aspirin (100 mg/d) for 7 days. Platelet aggregation function was detected using adenosine diphosphate (ADP) and arachidonic acid (AA) before and after the administration of aspirin. Then the subjects were divided into three groups according to the results of platelet aggregation function: an aspirin resistant (AR) group, an aspirin semi-responder (ASR) group and an aspirin-sensitive (AS) group. Platelet GP Ⅰa gene 807CT polymorphism was examined by means of polymerase chain reaction-sequence specific primers (PCR-SSP). The results showed that T allelic frequency in AR group and ASR group were higher that of AS group (P〈0.005), and the prevalence of genotypes (TT+TC) of these two groups was significantly higher than that in AS group (P〈0.05). Platelet GP Ⅰa T allele was significantly associated with aspirin resistance as revealed by multiple logistic regression (OR=3.76, 95% CI: 2.87-9.58). The results suggest that inherited platelet GP Ⅰa variations may have an important impact on aspirin resistance and the presence of GP Ⅰa T allele may be a marker of genetic susceptibility to aspirin resistance. 展开更多
关键词 platelet membrane glycoprotein aspirin resistance genetic polymorphism ATHEROSCLEROSIS
下载PDF
The removal of Cr(Ⅵ) through polymeric supported liquid membrane by using calix[4]arene as a carrier 被引量:1
4
作者 Canan Onac Ahmet Kaya +2 位作者 Duygu Ataman Nefise Ayhan Gunduz H.Korkmaz Alpoguz 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2019年第1期85-91,共7页
In this work, the transport and removal of Cr(Ⅵ) were achieved through supported liquid membrane(SLM) by using a 5,17, di-tert-butyl-11,23-bis[(1,4-dioxa-8-azaspiro [4,5]decanyl)methyl]-25,26,27,28-tetrahydroxy calix... In this work, the transport and removal of Cr(Ⅵ) were achieved through supported liquid membrane(SLM) by using a 5,17, di-tert-butyl-11,23-bis[(1,4-dioxa-8-azaspiro [4,5]decanyl)methyl]-25,26,27,28-tetrahydroxy calix[4]arene carrier, dissolved in 2-nitrophenyl octyl ether dichloromethane.The studied parameters are the solvent effect in the membrane phase, the effect of carrier concentration, and the acid type in the donor phase.The Celgard 2500 was used as a membrane support.We used the Danesi mass transfer model to calculate the permeability coefficients for each studied parameter.In addition, AFM and SEM techniques were used to characterize the surface morphology of the prepared Celgard 2500 membrane that included the calix[4]arene carrier. 展开更多
关键词 RESORCINARENE Liquid membrane Cr() Surface characterization
下载PDF
Redistribution of Platelet Membrane Glycoprotein IV and Release of Intracellular α-granule Thrombospondin in Patients with Chronic Myelogenous Leukemia
5
作者 刘东旭 沈迪 +3 位作者 邹萍 魏文宁 王爱莲 杨锐 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 1997年第1期21-24,共4页
The redistribution of platelet membrane glycoprotein IV (GPIV) and the release of intracellular Q-granule thrombospondin (TSP) were examined and the inhibition of 5-thromboglobulin (&TG) and platelet factor 4 (PF4... The redistribution of platelet membrane glycoprotein IV (GPIV) and the release of intracellular Q-granule thrombospondin (TSP) were examined and the inhibition of 5-thromboglobulin (&TG) and platelet factor 4 (PF4) in patients with chronic myelogenous leukemia (CML) was observed and quantitation of β-TG and PF4 in sera was conducted. GPIV in inactive platelet from CML was 36080±17010 molecules/platelet as compared with 13190±4810 from the controls (P<0,01), No abnormality was found in the distribution of platelet membrane GPIb and GPIIb/III.(P>0. 05). The GPIV redistribution on active platelet membrane induced thrombin (1U/ml) from CML and healthy donors was 44320132310 and 228001 12700 molecules/platelet respectively (P<0. 01 ). The difference in the release of intracellular Q-granule TSP between CML and the control group was not found (P>0.05). There was no direct correlation between GPIV expression and TSP binding after platelet activation. The high leveIs of β-TG and PF4 in sera inhibited release of intracellular a-granule TSP in vitro. These results indicate that the abnormality of platelet membrane GPIV is a common marker in CML, therefore the specific increase of platelet GPIV in patients with CML may be a useful tool for the diagnosis and monitoring of the platelet dysfunction. The release of interna1 TSP pools is hindered by either β-TG or PF4 in sera. 展开更多
关键词 chronic myelogenous leukemia platelet membrane glycoprotein IV THROMBOSPONDIN
下载PDF
Membrane glycoprotein M6A promotes μ-opioid receptor endocytosis and facilitates receptor sorting into the recycling pathway
6
作者 Ying-Jian Liang Dai-Fei Wu Ralf Stumm Volker Hǒllt Thomas Koch 《Cell Research》 SCIE CAS CSCD 2008年第7期768-779,共12页
The interaction of p-opioid receptor (MOPr) with the neuronal membrane glycoprotein M6a is known to facilitate MOPr endocytosis in human embryonic kidney 293 (HEK293) cells. To further study the role of M6a in the... The interaction of p-opioid receptor (MOPr) with the neuronal membrane glycoprotein M6a is known to facilitate MOPr endocytosis in human embryonic kidney 293 (HEK293) cells. To further study the role of M6a in the post-endocytotic sorting of MOPr, we investigated the agonist-induced co-internalization of MOPr and M6a and protein targeting after internalization in HEK293 cells that co-expressed HA-tagged MOPr and Myc-tagged M6a. ,We found that M6a, MOPr, and Rab 11, a marker for recycling endosomes, co-localized in endocytotic vesicles, indicating that MOPr and M6a are primarily targeted to recycling endosomes after endocytosis. Furthermore, co-expression of M6a augmented the post-endocytotic sorting of 6-opioid receptors into the recycling pathway, indicating that M6a might have a more general role in opioid receptor post-endocytotic sorting. The enhanced post-endocytotic sorting of MOPr into the recycling pathway was accompanied by a decrease in agonist-induced receptor down-regulation of M6a in co-expressing cells. We tested the physiological relevance of these findings in primary cultures of cortical neurons and found that co-expression of M6a markedly increased the translocation of MOPrsfrom the plasma membrane to intracellular vesicles at steady state and significantly enhanced both constitutive and agonist-induced receptor endocytosis. In conclusion, our results strongly indicate that M6a modulates MOPr endocytosis and post-endocytotic sorting and has an important role in receptor regulation. 展开更多
关键词 μ-opioid receptor membrane glycoprotein M6a INTERNALIZATION RECYCLING post-endocytotic sorting
下载PDF
电去离子法(EDI)处理含Cr(Ⅵ)废水
7
作者 邓恩鹏 王译旋 +2 位作者 田鹏 苗雨欣 康艳红 《化工环保》 CAS CSCD 北大核心 2024年第1期68-72,共5页
采用电去离子法(EDI)处理模拟含Cr(Ⅵ)废水,考察了电压、pH、电解时间和Cu2+等因素对Cr(Ⅵ)去除率和阴离子交换膜性能的影响。实验结果表明:随着电压的增加,阴离子交换膜对Cr(Ⅵ)的透过率逐渐增大,Cr(Ⅵ)去除率逐渐升高;随着电压的增加... 采用电去离子法(EDI)处理模拟含Cr(Ⅵ)废水,考察了电压、pH、电解时间和Cu2+等因素对Cr(Ⅵ)去除率和阴离子交换膜性能的影响。实验结果表明:随着电压的增加,阴离子交换膜对Cr(Ⅵ)的透过率逐渐增大,Cr(Ⅵ)去除率逐渐升高;随着电压的增加,阴离子交换膜对Cr(Ⅵ)的吸附率呈先增大后减小的趋势,20 V时,达到最大,为22.0%;pH为1.0~9.0时,对Cr(Ⅵ)去除率和阴离子交换膜性能的影响不大;在Cr(Ⅵ)初始质量浓度109.5 mg/L、电压20 V、pH 6.0~7.0、电解时间60 min的条件下,Cr(Ⅵ)去除率可达94.4%;Cu^(2+)(初始质量浓度100.3 mg/L)的存在使Cr(Ⅵ)去除率降低至80.2%,降低了14.2个百分点。 展开更多
关键词 离子膜 Cr() 去除率 透过率 吸附率
下载PDF
In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines 被引量:4
8
作者 Dennis Hoffmann Wibke Bayer Oliver Wildner 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第22期3063-3070,共8页
AIM: To evaluate whether intratumoral expression of measles virus fusogenic membrane glycoproteins H and F (MV-FMG), encoded by an adenovirus vector Ad.MV-HI F, alone or in combination with local coexpression of cy... AIM: To evaluate whether intratumoral expression of measles virus fusogenic membrane glycoproteins H and F (MV-FMG), encoded by an adenovirus vector Ad.MV-HI F, alone or in combination with local coexpression of cytokines (IL-2, IL-12, IL-18, IL-21 or GM-CSF), can serve as a platform for inducing tumor-specific immune responses in colon cancer.METHODS: We used confocal laser scanning microscopy and flow cytometry to analyze cell-cell fusion after expression of MV-FMG by dye colocalization. In a syngeneic bilateral subcutaneous MC38 and Colon26 colon cancer model in C57BL/6 and BALB/c mice, we assessed the effect on both the directly vector-treated tumor as well as the contralateral, not directly vector- treated tumor. We assessed the induction of a tumorspecific cytotoxic T lymphocyte (CTL) response with a lactate dehydrogenase (LDH) release assay.RESULTS: We demonstrated in vitro that transduction of MC38 and Colon26 cells with Ad.MV-H/F resulted in dye colocalization, indicative of cell-cell fusion, in addition, in the syngeneic bilateral tumor model we demonstrated a significant regression of the directly vector-inoculated tumor upon intratumoral expression of MV-FMG alone or in combination with the tested cytokines. We observed the highest anti-neoplastic efficacy with MV-FMG and lL-21 coexpression. The degree of tumor regression of the not directly vector-treated tumor correlated with the anti-neoplastic response of the directly vector-treated tumor. This regression was mediated by a tumor-specific CTL response.CONCLUSION: Our data indicate that intratumoral expression of measles virus fusogenic membrane glycoproteins is a promising tool both for direct tumor treatment as well as for tumor vaccination approaches that can be further enhanced by cytokine coexpression. 展开更多
关键词 Adenovirus vectors Measles virus fusogenic membrane glycoproteins Colorectal cancer INTERLEUKINS
下载PDF
原发与继发免疫性血小板减少症患者血小板膜糖蛋白特异性抗体及其与出血评分关系的研究 被引量:1
9
作者 王秀娟 孙明玲 +2 位作者 马金忠 宋梦婷 郭新红 《中国现代医学杂志》 CAS 2024年第1期78-83,共6页
目的探讨原发与继发免疫性血小板减少症(ITP)患者抗GPⅡb/Ⅲa及GPΙb/Ⅸ抗体的表达、抗体阳性表达与出血评分的关系,以及不同抗体类型出血评分的差异,为原发与继发ITP患者的诊治和出血严重程度提供临床依据。方法选取2013年10月—2020年... 目的探讨原发与继发免疫性血小板减少症(ITP)患者抗GPⅡb/Ⅲa及GPΙb/Ⅸ抗体的表达、抗体阳性表达与出血评分的关系,以及不同抗体类型出血评分的差异,为原发与继发ITP患者的诊治和出血严重程度提供临床依据。方法选取2013年10月—2020年8月在新疆医科大学第一附属医院诊断为原发ITP患者(42例)及继发ITP患者(42例)为研究对象,所有患者入院时采用ITP出血评分量表行出血评分。应用改良MAIPA法检测患者抗GPⅡb/Ⅲa和抗GPΙb/Ⅸ抗体。结果原发与继发组患者抗GPⅡb/Ⅲa抗体、抗GPΙb/Ⅸ抗体阳性率比较,差异无统计学意义(P>0.05),原发组患者抗体表达以抗GPⅡb/Ⅲa抗体为主,继发组抗体表达以抗GPΙb/Ⅸ抗体为主,两者抗体阳性构成比较,差异有统计学意义(P<0.05)。继发组患者整体出血程度较原发组重(P<0.05)。抗体阳性表达与出血程度的关系:(1)抗GPⅡb/Ⅲa抗体阳性患者出血程度较抗体阴性患者重(P<0.05)。(2)抗GPΙb/Ⅸ抗体阳性患者出血程度较抗体阴性患者重(P<0.05),双抗体阳性患者出血程度较抗体阴性患者重(P<0.05)。结论抗GPⅡb/Ⅲa抗体、抗GPΙb/Ⅸ抗体阳性表达对原发与继发ITP无鉴别意义,但原发ITP患者抗体表达以抗GPⅡb/Ⅲa抗体为主,继发ITP患者抗体表达以抗GPΙb/Ⅸ抗体为主。继发ITP患者临床出血程度较原发ITP患者重。抗GPⅡb/Ⅲa抗体、抗GPΙb/Ⅸ抗体及抗体双阳性患者出血程度较抗体阴性患者重。 展开更多
关键词 免疫性血小板减少症 血小板膜糖蛋白特异性抗体 出血评分
下载PDF
交联海藻酸钠固定化的腐殖酸多孔性薄膜对铀(Ⅵ)的吸附性能及机理 被引量:16
10
作者 谢水波 段毅 +2 位作者 刘迎九 王劲松 刘金香 《化工学报》 EI CAS CSCD 北大核心 2013年第7期2488-2496,共9页
采用戊二醛交联海藻酸钠固定化的腐殖酸,制备得到多孔性薄膜(GA-HA/SA),用于去除含铀废水中的铀(Ⅵ)。通过静态吸附实验,研究了pH值、初始浓度、接触时间、温度对GA-HA/SA吸附U(Ⅵ)效果的影响,进行了吸附过程的热力学与动力学分析;通过... 采用戊二醛交联海藻酸钠固定化的腐殖酸,制备得到多孔性薄膜(GA-HA/SA),用于去除含铀废水中的铀(Ⅵ)。通过静态吸附实验,研究了pH值、初始浓度、接触时间、温度对GA-HA/SA吸附U(Ⅵ)效果的影响,进行了吸附过程的热力学与动力学分析;通过红外光谱(FTIR)、扫描电镜(SEM)、X射线能谱(EDS)探讨了相关吸附机理。实验结果表明,pH值为6时吸附效果最好,吸附在60min基本达到平衡。吸附过程符合Langmuir和Dubinin-Radushkevich(D-R)等温模型;25℃时,最大吸附容量为312.5mg·g-1。吸附动力学过程符合准二级速率方程(R2>0.99),吸附速率的控速步骤为颗粒内扩散。GA-HA/SA对U(Ⅵ)的吸附是自发的吸热反应。SEM-EDS、FTIR和D-R模型分析结果表明,与U(Ⅵ)相互作用的基团主要是羧基,且GA-HA/SA吸附U(Ⅵ)的机理表现为离子交换。 展开更多
关键词 多孔性薄膜 铀() 热力学 动力学 速率控制 吸附机理
下载PDF
基于Donnan渗析的阴离子交换膜分离饮用水中Cr(Ⅵ)研究 被引量:9
11
作者 施周 李学瑞 +1 位作者 陈世洋 邓林 《安全与环境学报》 CAS CSCD 北大核心 2013年第3期78-82,共5页
基于Donnan渗析原理,研究阴离子交换膜分离饮用水中的Cr(Ⅵ),探讨受体液种类、受体液NaCl浓度、给体液初始pH值以及给体液进水流速对Cr(Ⅵ)分离的影响。结果表明,不同驱动离子条件下给体池中Cr(Ⅵ)的分离去除率从大到小依次为Cl-... 基于Donnan渗析原理,研究阴离子交换膜分离饮用水中的Cr(Ⅵ),探讨受体液种类、受体液NaCl浓度、给体液初始pH值以及给体液进水流速对Cr(Ⅵ)分离的影响。结果表明,不同驱动离子条件下给体池中Cr(Ⅵ)的分离去除率从大到小依次为Cl-、HCO3-、SO24-,而离子通量从大到小依次为Cl-、SO24-、HCO3-。驱动离子宜为水合半径较小的单价Cl-,受体液应为相对廉价常见的NaCl溶液。当受体液NaCl浓度由0增加至0.100mol/L时,给体池中Cr(Ⅵ)的分离去除率变化不大,而离子通量由0显著提高至7.34×10-5mg/(cm^2.min);进一步增加受体液NaCl浓度至0.5 mol/L,给体池中Cr(Ⅵ)的分离去除率和离子通量的增加较小。当给体液初始pH值为1.0时,给体池中Cr(Ⅵ)的分离去除率和离子通量较小,并随给体液初始pH值的增大而增大。该Cr(Ⅵ)分离过程在饮用水常规pH值范围(6.5~8.5)内均能得到较好的效果。当给体液进水流速由1.0 mL/min增加至5.0mL/min时,给体池中Cr(Ⅵ)的分离去除率由89.3%降低至73.5%,离子通量由6.25×10-5mg/(cm^2.min)增加至8.91×10-5mg/(cm^2.min)。饮用水中背景组分对Cr(Ⅵ)分离的影响不大。 展开更多
关键词 市政工程 六价铬 阴离子交换膜 Donnan渗析
下载PDF
有机/无机杂化膜的制备及其吸附脱除水溶液中的Cr(Ⅵ) 被引量:3
12
作者 张扬 王吉林 +2 位作者 王璐璐 封瑞江 张帆 《化工新型材料》 CAS CSCD 北大核心 2017年第4期94-97,共4页
以正硅酸乙酯(TEOS)为无机前驱体,季铵化聚乙烯醇(QPVA)为有机基质,采用溶胶-凝胶法制备QPVA/TEOS有机/无机杂化膜,并将其作为吸附材料用于脱除水溶液中的Cr(Ⅵ)离子。结果表明,具有较好吸附效果的膜为TEOS质量分数为15%的有机/无机杂... 以正硅酸乙酯(TEOS)为无机前驱体,季铵化聚乙烯醇(QPVA)为有机基质,采用溶胶-凝胶法制备QPVA/TEOS有机/无机杂化膜,并将其作为吸附材料用于脱除水溶液中的Cr(Ⅵ)离子。结果表明,具有较好吸附效果的膜为TEOS质量分数为15%的有机/无机杂化膜。在Cr(Ⅵ)离子初始浓度为90mg/L的条件下,复合膜的最优吸附工作条件为吸附时间为100min,pH=3。此时计算得到的最佳吸附容量为20mg/g。动力学研究表明,实验数据符合拟二级吸附动力学模型,等温吸附遵循Freundlich曲线。热力学数据表明,该吸附反应为吸热的自发过程。 展开更多
关键词 杂化 吸附 Cr()
下载PDF
利用氢基质生物膜反应器去除地下水中的Cr(Ⅵ) 被引量:6
13
作者 夏四清 杨昕 +1 位作者 钟佛华 李海翔 《同济大学学报(自然科学版)》 EI CAS CSCD 北大核心 2010年第9期1303-1308,1328,共7页
采用氢基质生物膜反应器(hydrogen-based membrane biofilm reactor,MBfR)生物去除地下水中的Cr(Ⅵ).MBfR膜表面氢自养还原菌利用氢气作为电子供体,进行自养还原反应,使水中Cr(Ⅵ)还原为Cr(Ⅲ),形成沉淀而去除.通过培养生物膜、改变进水... 采用氢基质生物膜反应器(hydrogen-based membrane biofilm reactor,MBfR)生物去除地下水中的Cr(Ⅵ).MBfR膜表面氢自养还原菌利用氢气作为电子供体,进行自养还原反应,使水中Cr(Ⅵ)还原为Cr(Ⅲ),形成沉淀而去除.通过培养生物膜、改变进水Cr(Ⅵ)质量浓度和氢分压,启动驯化120 d后Cr(Ⅵ)去除率达83%,NO3--N去除率高于99%.3种影响因素的试验研究表明:氢分压、NO3--N负荷和pH值对Cr(Ⅵ)的去除有影响.增加氢分压有利于Cr(Ⅵ)的去除;而NO3--N负荷的增加则导致Cr(Ⅵ)去除效率降低;Cr(Ⅵ)还原对pH值较为敏感,最佳pH值为7.0(最高去除率达78.2%),pH值小于7.0或大于8.0时都会造成去除率显著降低.试验表明,利用氢基质生物膜反应器处理含Cr(Ⅵ)以及NO3--N和Cr(Ⅵ)污染共存的地下水体具有一定应用潜力,关键控制因素有氢分压、NO3--N质量浓度和pH值. 展开更多
关键词 Cr() 氢基质生物膜反应器 影响因素 地下水
下载PDF
含Cr(Ⅵ)废水处理研究进展 被引量:12
14
作者 肖轲 徐夫元 +1 位作者 降林华 段宁 《北京师范大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第1期76-82,共7页
含Cr(Ⅵ)废水若直接排放会造成严重的环境污染,也会对人体健康产生不良影响,因此需处理达标后排放.目前,含Cr(Ⅵ)废水处理方法的研究主要集中于吸附法、膜分离法、离子交换法、电化学法和生物法等,本文结合近几年含Cr(Ⅵ)废水处理研究成... 含Cr(Ⅵ)废水若直接排放会造成严重的环境污染,也会对人体健康产生不良影响,因此需处理达标后排放.目前,含Cr(Ⅵ)废水处理方法的研究主要集中于吸附法、膜分离法、离子交换法、电化学法和生物法等,本文结合近几年含Cr(Ⅵ)废水处理研究成果,着重阐述了各种方法处理含Cr(Ⅵ)废水的原理、优缺点和研究现状. 展开更多
关键词 含Cr()废水 吸附法 膜分离法 离子交换法 电化学法 生物法
下载PDF
皮胶原固化单宁膜材料的制备及其对U(Ⅵ)的吸附研究 被引量:4
15
作者 马贺伟 廖学品 石碧 《膜科学与技术》 CAS CSCD 北大核心 2005年第2期20-24,29,共6页
以天然皮胶原纤维膜为底物,通过醛类化合物的交联剂作用,将毛杨梅单宁(myricarubra)固定在皮胶原纤维上,制备出新型的膜吸附材料.系统研究了这种膜吸附材料对水溶液中U(Ⅵ)的吸附特性,结果表明:当温度为303K、pH5.0、U(Ⅵ)的初始浓度为2... 以天然皮胶原纤维膜为底物,通过醛类化合物的交联剂作用,将毛杨梅单宁(myricarubra)固定在皮胶原纤维上,制备出新型的膜吸附材料.系统研究了这种膜吸附材料对水溶液中U(Ⅵ)的吸附特性,结果表明:当温度为303K、pH5.0、U(Ⅵ)的初始浓度为263.15mg/L时,每克固化单宁膜吸附U(Ⅵ)的平衡吸附量为56.83mg,而且平衡吸附量随着温度的升高进一步增大;pH对吸附容量的影响较大,适宜的pH范围在5.0~8.0;这类膜材料的吸附平衡符合Freundlich方程,静态吸附动力学可以用拟二级速度方程来描述.连续吸附实验表明,当原料液中U(Ⅵ)的浓度为263.15mg/L、流出液体积为500mL时,单层膜的吸附率可达到90%以上;而用三层膜时,当流出液体积达到1000mL时也未在流出液中检测到U(Ⅵ).该类膜吸附U(Ⅵ)后用0.1mol/L的HNO3很容易解吸,而且再生后其吸附容量和性能基本不变. 展开更多
关键词 U() 膜材料 皮胶原 吸附研究 单宁 FREUNDLICH方程 制备 固化 平衡吸附量 吸附材料 吸附容量 醛类化合物 吸附动力学 胶原纤维 吸附特性 系统研究 初始浓度 pH范围 吸附平衡 吸附实验 速度方程 HNO3 纤维膜 交联剂 水溶液
下载PDF
微孔滤膜富集分离光度法测定废水中痕量铬(Ⅵ) 被引量:4
16
作者 徐忠鹏 王雪莹 +2 位作者 王蕾 孙辉 罗川南 《工业水处理》 CAS CSCD 北大核心 2008年第12期77-80,共4页
利用微孔滤膜富集分离铬天青S-铬(Ⅵ)-溴化十六烷基吡啶三元配合物,用二甲基亚砜将膜及配合物溶解,分光光度法测定吸光度,建立了检测痕量铬(Ⅵ)的新方法。配合物在溶液中的最大吸收波长600nm,表观摩尔吸光系数为1.25×105L/(mol.cm)... 利用微孔滤膜富集分离铬天青S-铬(Ⅵ)-溴化十六烷基吡啶三元配合物,用二甲基亚砜将膜及配合物溶解,分光光度法测定吸光度,建立了检测痕量铬(Ⅵ)的新方法。配合物在溶液中的最大吸收波长600nm,表观摩尔吸光系数为1.25×105L/(mol.cm),铬的质量浓度在0~0.6000mg/L范围内符合比尔定律,相关系数为0.9945。该方法灵敏度高,选择性好,简便,测定工业废水中痕量铬(Ⅵ)的结果令人满意。 展开更多
关键词 微孔滤膜 富集 分离 分光光度计 铬()
下载PDF
双烯基丁二酰亚胺/磷酸三丁酯/煤油液膜分离富集废水中微量铬(Ⅵ) 被引量:3
17
作者 廖辉伟 郑敏 +2 位作者 穆兰 孟艳艳 张夏力 《冶金分析》 CAS CSCD 北大核心 2009年第4期41-45,共5页
采用双烯基丁二酰亚胺(L113B)代替表面活性剂失水山梨醇单油酸酯(Span80),以磷酸三丁酯(TBP)和煤油作为油膜相,NaOH溶液作为内水相,制备了W/O/W型双重乳液。研究了乳化速度、乳化时间、表面活性剂用量、载体和稀释剂用量、内相溶液浓度... 采用双烯基丁二酰亚胺(L113B)代替表面活性剂失水山梨醇单油酸酯(Span80),以磷酸三丁酯(TBP)和煤油作为油膜相,NaOH溶液作为内水相,制备了W/O/W型双重乳液。研究了乳化速度、乳化时间、表面活性剂用量、载体和稀释剂用量、内相溶液浓度、油内比和乳水比等因素对体系稳定性及铬(Ⅵ)萃取率的影响,并对其萃取机理进行了分析。比较了两种乳液在Cr(Ⅵ)萃取率上的差异以及破乳后乳液回用情况。结果表明,在酸性条件下该体系具有良好的稳定性,液膜的溶胀率为8.4%,破损率为0.1%,铬(Ⅵ)的萃取率为99.4%,回收乳液再次萃取率可达95%以上。 展开更多
关键词 乳状液膜 铬() 分离富集 萃取机理
下载PDF
以三正辛胺为流动载体的乳状液膜迁移和分离Mo(Ⅵ)的研究 被引量:3
18
作者 李全民 李克安 +1 位作者 邹长英 童沈阳 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 1993年第2期171-174,共4页
用三正辛胺-SPAN 80-二甲苯乳状液膜体系迁移Mo(Ⅵ)的研究表明,在合适的制乳和迁移条件下,Mo(Ⅵ)可以快速、完全地迁入内相,并能与Fe^(2+)、Cu^(2+)、Co^(2+)、Ni^(2+)、Zn^(2+)、Cd^(2+)、Mn^(2+)等常见离子分离。
关键词 乳状液膜 三正辛胺 迁移 分离 钼() 流动载体 分光光度法 测定
下载PDF
液膜法去除水中Cr(Ⅵ)的研究 被引量:5
19
作者 李硕文 陈扬 万伟 《水处理技术》 CAS CSCD 1997年第3期151-155,共5页
本文采用液膜去除回收水中Cr(Ⅵ)。对膜溶剂、载体、稳定剂的种类及用量进行了优选。用优选出的膜配方制成乳液处理含Cr(Ⅵ)水样,对制膜速度及时间、混合速度及时间、内外水相pH、膜内比及乳水比等操作条件对Cr(Ⅵ)去除... 本文采用液膜去除回收水中Cr(Ⅵ)。对膜溶剂、载体、稳定剂的种类及用量进行了优选。用优选出的膜配方制成乳液处理含Cr(Ⅵ)水样,对制膜速度及时间、混合速度及时间、内外水相pH、膜内比及乳水比等操作条件对Cr(Ⅵ)去除率的影响进行了研究。 展开更多
关键词 液膜分离技术 废水处理 含铬废水 膜溶剂
下载PDF
离子交换耦合膜分离技术回用电镀废水中Cr(Ⅵ)技术研究 被引量:5
20
作者 刘国昌 冯世业 +4 位作者 李浩 周从章 黄振华 李雪梅 吕经烈 《安全与环境学报》 CAS CSCD 北大核心 2015年第4期240-243,共4页
为实现电镀废水中6价铬离子(Cr(Ⅵ))回用,将纳滤技术与离子交换技术耦合,建立了1 m3/h中试试验装置。含Cr(Ⅵ)废水经离子交换纤维吸附处理,出水Cr(Ⅵ)质量浓度≤0.08 mg/L,可达标排放;将离子交换纤维吸附饱和后再生,获得5 000 mg/L以上... 为实现电镀废水中6价铬离子(Cr(Ⅵ))回用,将纳滤技术与离子交换技术耦合,建立了1 m3/h中试试验装置。含Cr(Ⅵ)废水经离子交换纤维吸附处理,出水Cr(Ⅵ)质量浓度≤0.08 mg/L,可达标排放;将离子交换纤维吸附饱和后再生,获得5 000 mg/L以上Cr(Ⅵ)浓缩液,同时含有Cl-。采用纳滤膜处理该浓缩液,将Cr(Ⅵ)与Cl-分离。对比研究了运行压力和离子质量浓度对分离效果的影响,由此筛选较适宜膜产品。结果表明:进水Cr(Ⅵ)质量浓度为3 680mg/L,Cl-质量浓度为16 049 mg/L,运行压力为0.7 MPa,Cr(Ⅵ)截留率为80%,Cl-完全透过;溶液p H=8和p H=11时纳滤膜对Cr(Ⅵ)、Cl-分离效果无显著差异;经过60 d试验纳滤膜的脱盐性能无衰减。将离子交换与纳滤技术耦合,连续运行,能获得Cr(Ⅵ)质量浓度为3 200 mg/L、Cl-质量浓度为20 mg/L的浓缩液。研究表明,集成工艺整体可行,具有潜在应用价值。 展开更多
关键词 环境工程学 分离过程 离子交换纤维 电镀废水 铬离子 纳滤膜
下载PDF
上一页 1 2 38 下一页 到第
使用帮助 返回顶部